Moderna To Ask For Clearance For Combination COVID-Influenza Vaccine

Moderna is going to ask regulators to approve its combination vaccine against COVID-19 and influenza, the company said on June 30.

The company said a phase 3 study evaluating its influenza vaccine candidate, mRNA-1010—which utilizes the same messenger ribonucleic acid (mRNA) platform as its COVID-19 vaccine—showed positive effectiveness.

In the trial, which featured 40,805 participants and compared mRNA-1010 to an existing seasonal flu vaccine in adults aged 50 and up, the relative protection from the candidate was 26.6 percent better. In a subgroup analysis among participants aged at least 65, the relative efficacy was 27.4 percent.

Today’s strong Phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in older adults,” Stéphane Bancel, Moderna’s CEO, said in a statement.

Several companies, including Moderna, have been planning to introduce combination shots against COVID-19 and influenza.

Moderna, however, in May withdrew its application for approval for its combination vaccine, a move the company said came after consulting with the Food and Drug Administration.

Moderna at the time said it planned to resubmit the application before the end of 2025 after it received efficacy data from the phase 3 trial for mRNA 1010.

“An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines,” Bancel said on Monday.

The trial results have been fully published or peer reviewed. Moderna said it plans to submit the results to a peer-reviewed journal.

Keep reading

Judge Awards $4 Million to St. Louis Public School Employees Who Sued Over Vaccine Mandate

A jury ruled on Thursday in favor of 13 employees with the St. Louis Public Schools System who were forced to take the COVID vaccine despite religious objections.

The court awarded the 13 employees $4 million for the injustice.

According to Schrag on Law, the plaintiffs Wanda Brandon and over a dozen other current and former employees in the St. Louis Public Schools system,  sued the Board of Education of the City of St. Louis, Superintendent Kelvin Adams, and Chief Human Resources Officer Charles Burton in the Eastern District of Missouri raising claims of violations of the First Amendment’s Free Exercise Clause, the Fourteenth Amendment’s Equal Protection Clause, Title VII religious discrimination, and the Missouri Human Rights Act.

In fall of 2021 during the height of the COVID pandemic, the St. Louis Board of Education adopted Policy 4624, requiring all employees to be fully vaccinated against COVID-19 by October 15, 2021, or obtain an approved exemption.

The sixteen original plaintiffs submitted religious exemption forms to their employer. The employees cited their Christian, Islamic and Pentacostal beliefs that conflicted with the vaccine that was developed from fetal cell lines.

The St. Louis Board denied all 189 of the religious exemption requests and forced the employees to take the experimental vaccine.

The Board then suspended or terminated the employees who refused to take the COVID vaccine.

Keep reading

VICTORY! After Four Years and Two Months British Nursing Council Drops Charges Against Dr. Niall McCrae for Publishing His Completely Factual Report on COVID Vaccine Risks on The Gateway Pundit in 2021

In the covid debacle, health professions played a major role in enforcing the official narrative. I can now reveal my experience with the UK Nursing & Midwifery Council (NMC), who charged me with contradicting government guidance on vaccination and risking patients’ lives, after writing an entirely factual article on Gateway Pundit.

As a senior lecturer in psychiatric nursing at King’s College London, the NMC was my professional regulator.

When covid vaccines were introduced, I feared that blind faith and propaganda about an oxymoronic ‘miracle of science’ would lead to less impressive and harmful outcomes.

On 4th March 2021, Gateway Pundit published my article ‘British government study confirms Covid-19 vaccine risk’.  The article is linked below. This related to a Public Health England report showing increased infections soon after vaccination, which I attributed to a known phenomenon of temporary depletion in immunity.

Although factually accurate, a fact-check website labeled my article as ‘misleading’. On 8th March I was notified by the NMC of a referral by a ‘Dr Byrne’, who had seen my writing and found me on the register. The NMC began an investigation of my fitness to practise, alleging ‘failure to uphold your position as a registered nurse – in that you promoted health advice contrary to official health advice in the context of a global pandemic’.

From the outset, I was confident that the NMC had no reasonable case against me. I submitted my statement, supported by three experts (physician Helen Westwood, biostatistician Paul Cuddin, and nursing professor Roger Watson.  Cuddin wrote: ‘on the basis that there is consistent, increasing real-world and clinical evidence of increased infections in the two weeks after vaccination, the points raised by Dr Niall McCrae need to be addressed as a matter of urgency.’

Keep reading

Nearly 10,000 Claims Pending as COVID Vaccine Injury Compensation Program Faces Possible Budget Cut

A government-run COVID-19 vaccine injury compensation program with nearly 10,000 pending claims faces the threat of a budget cut for the 2026 fiscal year.

The Trump administration’s proposed budget would eliminate funding for the Countermeasures Injury Compensation Program (CICP), TrialSite News reported last week. If approved, the program would be forced to operate on “carryover funds” — or unspent funds from previous years.

According to TrialSite News:

“With no civil court recourse under the PREP Act, downgrading CICP funding leaves injured individuals with limited legal avenues and uncertain financial relief. This undermines public trust in vaccine policy, risks fueling hesitancy, and may deter future claim filings altogether.

“The decision to drop new CICP funding was hidden in budget pages — no public announcements or detailed breakdown of carryover metrics. How much carryover exists? How long will it last? What if claim volume increases?”

CICP was established under the Public Readiness and Emergency Preparedness Act (PREP Act) of 2005.

Under a PREP Act declaration, issued during an official public health emergency such as the COVID-19 pandemic, manufacturers of vaccines and other countermeasures associated with a health emergency are exempt from liability for serious injuries or death caused by their products — except in cases of willful misconduct.

That means people who believe they were injured by one of these products can’t sue the manufacturer. Instead, they can apply to the CICP for compensation.

However, even if successful, claimants often receive limited compensation from CICP. By law, the program can reimburse only those medical expenses not compensated by insurance or other programs.

It can also reimburse for lost employment income (capped at $50,000 per year) and a one-time benefit of $370,000 for deaths.

The program does not reimburse legal fees or provide compensation for pain and suffering.

Keep reading

ACIP Members Push Back on CDC’s COVID Vaccine Safety Claims

The Centers for Disease Control and Prevention’s (CDC) COVID-19 vaccine work group today assured the agency’s new panel of vaccine advisers that the vaccines are necessary, effective and have no safety concerns beyond a small risk of myocarditis among an age-limited group of young men.

The new members of the Advisory Committee on Immunization Practices (ACIP) pushed back on several claims made by the presenters, including the agency’s methods for assessing efficacy and safety.

They also questioned claims the group made about how dangerous the COVID-19 virus is, especially for children.

ACIP didn’t schedule a vote today on COVID-19 vaccines. The committee only heard data presentations by the work group and engaged in a question-and-answer session.

Today’s meeting was the first since U.S. Health and Human Services Secretary Robert F. Kennedy Jr. fired the previous 17 ACIP members and replaced them with eight (now seven) new members.

The work group members haven’t changed under the new administration.

Last month, Kennedy announced changes to the COVID-19 vaccination recommendations for children and pregnant women.

The CDC now recommends “shared clinical decision-making” between parents and providers for healthy children ages 6 months to 17 years who are not moderately immunocompromised. The agency changed its guidance on COVID-19 vaccines for pregnant women from recommended to “no guidance.”

After several hours of presentations, the work group concluded that the 2024-2025 vaccines were effective in preventing hospitalizations and critical outcomes from COVID-19 in adults, that there is robust safety surveillance with no known risks beyond myocarditis.

The group also concluded that pregnant women are at greater risk from COVID-19, and that maternal vaccination has been shown to protect infants — a claim unsupported by any data from the presentations, said Dr. Meryl Nass, who live-blogged the meeting for CHD.TV.

Keep reading

Former NY DEI Director and Hochul Aide Linda Sun CHARGED in Multimillion-Dollar PPE Fraud and Kickback Scheme

While New Yorkers were gasping for N-95 masks and latex gloves in the dark spring of 2020, the woman once tasked with “diversity, equity & inclusion” inside the Hochul-Cuomo political machine was allegedly busy funneling state contracts to her own relatives—and pocketing the profits.

The Gateway Pundit reported last year that the FBI conducted a pre-dawn raid on the $3.5 million Long Island home.

The lavish five-bedroom home, located in a gated community called Stone Hill in Long Island, was searched thoroughly by agents, though it remains undisclosed whether any items were seized during the operation.

A federal grand jury has returned a second superseding indictment against Linda Sun, former Director of Diversity, Equity & Inclusion for New York and later Deputy Chief of Staff to Gov. Kathy Hochul, along with her husband Christopher “Chris” Hu.

Prosecutors say the pair raked in more than $8 million in kickbacks, bribes and laundered cash by steering COVID-19 personal-protective-equipment (PPE) contracts to companies run by Sun’s cousin and Hu’s business partner.

The new counts include honest-services wire fraud, conspiracy, bribery, money-laundering, and—just for good measure—tax evasion for Hu. Arraignment is set for Monday, June 30 in U.S. District Court for the Eastern District of New York.

Keep reading

More Fetal Losses Than Expected After Pfizer COVID-19 Vaccination In Israel: Study

A higher-than-expected number of miscarriages and other forms of fetal loss were associated with COVID-19 vaccinations in Israel, a new study has revealed.

Researchers found 13 fetal losses—four more than the nine expected—for every 100 pregnant women who received a COVID-19 vaccine during weeks eight to 13 in pregnancy, according to the study, which was published as a preprint on the medRxiv server.

Most people in Israel, including pregnant women, received the Pfizer-BioNTech COVID-19 vaccine.

Pfizer did not respond by publication time to a request for comment.

The team behind the study includes Retsef Levi, a Massachusetts Institute of Technology researcher who was recently named to the committee that advises the Centers for Disease Control and Prevention on vaccines, and Dr. Tracy Hoeg, who works for the Food and Drug Administration.

The researchers analyzed electronic health records from Maccabi Healthcare Services, one of four organizations that provide health care to Israelis. They looked at 226,395 pregnancies that occurred between March 1, 2016, and Feb. 28, 2022. The primary analysis looked at fetal loss for pregnant women after dose one or dose three of a COVID-19 vaccine, with fetal loss including miscarriage, abortion, and stillbirth.

The researchers came up with an expected number of fetal losses based on a model that drew from data before the COVID-19 pandemic, then compared the expected number of fetal losses with those that occurred from week eight of pregnancy onward.

They identified 13,214 fetal losses after the COVID-19 pandemic started, compared with 12,846 fetal losses in the reference period, finding that women who received a COVID-19 vaccine during weeks eight to 13 in pregnancy experienced a higher-than-expected number of fetal losses.

“If you believe this result … every 100 women that you would vaccinate during weeks eight to 13, you are going to see close to four additional fetal losses,” Levi told The Epoch Times.

Keep reading

Did AI Almost Start World War III?

Recall that the Covid fiasco went into overdrive when Neil Ferguson of Imperial College London generated a wildly incorrect estimate of the fatality rate of the virus from China. He had two forecasts, one without lockdowns (death everywhere) and one with (not terrible). The idea was to inspire the replication of the CCP’s extreme methods of people control in the West. 

That model, first shared in classified realms, flipped the narrative. Once select advisors – Deborah Birx and Anthony Fauci among them – presented it to Trump, he went from opposing lockdowns to getting in front of the seemingly inevitable. 

Before long, every Gates-funded NGO was pushing more such models that proved the point. Masses of people observed the models as if they were an accurate reflection of reality. Major media reported on them daily. 

As the fiasco dragged on, so did data fakery. The PCR tests were generating false positives, giving the impression of an unfolding calamity even though medically significant infections were highly limited. Infections and even exposures were redefined as cases, for the first time in epidemiological history. Then came the subsidized “deaths from Covid” that clearly generated waves of misclassification that underscore the overestimation of the fatality rate.

Keep reading

SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis

Cancer is a complex and dynamic disease. The “hallmarks of cancer” were proposed by Hanahan and Weinberg (2000) as a group of biological competencies that human cells attain as they progress from normalcy to neoplastic transformation. These competencies include self-sufficiency in proliferative signaling, insensitivity to growth-suppressive signals and immune surveillance, the ability to evade cell death, enabling replicative immortality, reprogramming energy metabolism, inducing angiogenesis, and activating tissue invasion and metastasis. Underlying these competencies are genome instability, which expedites their acquisition, and inflammation, which fosters their function(s). Additionally, cancer exhibits another dimension of complexity: a heterogeneous repertoire of infiltrating and resident host cells, secreted factors, and extracellular matrix, known as the tumor microenvironment, that through a dynamic and reciprocal relationship with cancer cells supports immortality, local invasion, and metastatic dissemination. This staggering intricacy calls for caution when advising all people with cancer (or a previous history of cancer) to receive the COVID-19 primary vaccine series plus additional booster doses. Moreover, because these patients were not included in the pivotal clinical trials, considerable uncertainty remains regarding vaccine efficacy, safety, and the risk of interactions with anticancer therapies, which could reduce the value and innocuity of either medical treatment.

After reviewing the available literature, we are particularly concerned that certain COVID-19 vaccines may generate a pro-tumorigenic milieu (i.e., a specific environment that could lead to neoplastic transformation) that predisposes some (stable) oncologic patients and survivors to cancer progression, recurrence, and/or metastasis. This hypothesis is based on biological plausibility and fulfillment of the multi-hit hypothesis of oncogenesis (i.e., induction of lymphopenia and inflammation, downregulation of angiotensin-converting enzyme 2 (ACE2) expression, activation of oncogenic cascades, sequestration of tumor suppressor proteins, dysregulation of the RNA-G quadruplex-protein binding system, alteration of type I interferon responses, unsilencing of retrotransposable elements, etc.) together with growing evidence and safety reports filed to Vaccine Adverse Effects Report System (VAERS) suggesting that some cancer patients experienced disease exacerbation or recurrence following COVID-19 vaccination. In light of the above and because some of these concerns (i.e., alteration of oncogenic pathways, promotion of inflammatory cascades, and dysregulation of the renin-angiotensin system) also apply to cancer patients infected with SARS-CoV-2, we encourage the scientific and medical community to urgently evaluate the impact of both COVID-19 and COVID-19 vaccination on cancer biology and tumor registries, adjusting public health recommendations accordingly.

Keep reading

Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic

Abstract

Background

Adverse effects of COVID-19 vaccination on human menstrual cycle characteristics have been observed, but limited data are available on the relationship between COVID-19 vaccination status and birth rates.

Objectives

Therefore, we used nationwide data from the Czech Republic to examine rates of successful conceptions (SCs), that is, conceptions leading to live births 9 months later, for women who were either vaccinated or unvaccinated against COVID-19 before SC.

Methods

Summary monthly COVID-19 vaccination and birth data for women in the Czech Republic aged 18–39 years were retrieved for the period from January 2021 to December 2023. The numbers of SCs per month per 1000 women were calculated for preconception-vaccinated or unvaccinated women, respectively, as well as the number of SCs per month per 1000 women for all women aged 18–39 years.

Results

During the study period, there were approximately 1,300,000 women aged 18–39 years in the Czech Republic, and the proportion of COVID-19-vaccinated women increased from January 2021 until reaching a steady state of around 70% by the end of 2021. At least from June 2021, SCs per 1000 women were considerably lower for women who were vaccinated, compared to those that were unvaccinated, before SC. Furthermore, SC rates for the vaccinated group were much lower than expected based on their proportion of the total population.

Conclusions

In the Czech Republic, SC rates were substantially lower for women vaccinated against COVID-19 before SC than for those who were not vaccinated. These hypothesis-generating and preliminary results call for further studies of the potential influence of COVID-19 vaccination on human fecundability and fertility.

Keep reading